Home › Funds › Paradigm Biocapital Advisors LP › MPLT
Paradigm Biocapital Advisors LP position in MPLT
MAPLIGHT THERAPEUTICS INC · Health Care
Paradigm Biocapital Advisors LP reported holding 685,852 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$24.6M, representing 0.46% of its reported portfolio and ranking #24 among its reported holdings. Paradigm Biocapital Advisors LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Paradigm Biocapital Advisors LP's MPLT position evolved
Paradigm Biocapital Advisors LP first disclosed a stake in MPLT in Q2 2026 at 685,852 shares (US$24.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 685.85K | $24.58M | New |
About MPLT and 13F data
MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 118 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), Nan Fung Group Holdings Ltd (US$34.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MPLT
- Novo Holdings A/S 3.69M sh · $132.13M · Q2 2026
- FCPM III SERVICES B.V. 3.23M sh · $115.63M · Q2 2026
- Nan Fung Group Holdings Ltd 971.25K sh · $34.81M · Q2 2026
- 5AM Venture Management, LLC 950.01K sh · $34.05M · Q2 2026
- Sanofi 912.04K sh · $32.69M · Q2 2026
- Blue Owl Capital Holdings LP 729.93K sh · $26.16M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K sh · $21.91M · Q2 2026
- Velan Capital Investment Management LP 492.89K sh · $17.67M · Q2 2026
- DAFNA Capital Management LLC 171.01K sh · $6.13M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 125.43K sh · $4.50M · Q2 2026
- STEMPOINT CAPITAL LP 106.91K sh · $3.83M · Q2 2026
More on Paradigm Biocapital Advisors LP
FAQ
How long has Paradigm Biocapital Advisors LP held MPLT?
Paradigm Biocapital Advisors LP has disclosed MPLT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Paradigm Biocapital Advisors LP's current position in MPLT?
As of Q2 2026, Paradigm Biocapital Advisors LP holds 685.85K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $24.58M, representing 0.46% of its reported portfolio and ranking #24.
Has Paradigm Biocapital Advisors LP been buying or selling MPLT?
In the latest 13F filing (Q2 2026), Paradigm Biocapital Advisors LP newly opened its position in MPLT.
Which other funds hold MPLT?
Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, among 118 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.